Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) )
ClinicalTrials.gov Identifier:
NCT01662336
First received: August 8, 2012
Last updated: August 31, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2016
  Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)